IDEAS home Printed from https://ideas.repec.org/f/pgo960.html
   My authors  Follow this author

Susan Golder

Personal Details

First Name:Susan
Middle Name:
Last Name:Golder
Suffix:
RePEc Short-ID:pgo960

Affiliation

Centre for Health Economics
Department of Economics and Related Studies
University of York

York, United Kingdom
https://www.york.ac.uk/che/
RePEc:edi:chyoruk (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. golder, su & Stevens, Robin & O'Connor, Karen & James, Richard & Gonzalez-Hernandez, Graciela, 2021. "Who is Tweeting? A Scoping Review of Methods to Establish Race and Ethnicity from Twitter Datasets," SocArXiv wru5q, Center for Open Science.

Articles

  1. Su Golder & Davy Weissenbacher & Karen O’Connor & Sean Hennessy & Robert Gross & Graciela Gonzalez Hernandez, 2022. "Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media," Drug Safety, Springer, vol. 45(9), pages 971-981, September.
  2. Su Golder & Karen Smith & Karen O’Connor & Robert Gross & Sean Hennessy & Graciela Gonzalez-Hernandez, 2021. "Correction to: A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews," Drug Safety, Springer, vol. 44(2), pages 259-259, February.
  3. Golder, Su & McCambridge, Jim, 2021. "Alcohol, cardiovascular disease and industry funding: A co-authorship network analysis of systematic reviews," Social Science & Medicine, Elsevier, vol. 289(C).
  4. Su Golder & Karen Smith & Karen O’Connor & Robert Gross & Sean Hennessy & Graciela Gonzalez-Hernandez, 2021. "A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews," Drug Safety, Springer, vol. 44(2), pages 167-179, February.
  5. Su Golder & Stephanie Chiuve & Davy Weissenbacher & Ari Klein & Karen O’Connor & Martin Bland & Murray Malin & Mondira Bhattacharya & Linda J. Scarazzini & Graciela Gonzalez-Hernandez, 2019. "Pharmacoepidemiologic Evaluation of Birth Defects from Health-Related Postings in Social Media During Pregnancy," Drug Safety, Springer, vol. 42(3), pages 389-400, March.
  6. Karen Smith & Su Golder & Abeed Sarker & Yoon Loke & Karen O’Connor & Graciela Gonzalez-Hernandez, 2018. "Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab," Drug Safety, Springer, vol. 41(12), pages 1397-1410, December.
  7. Stephanie W. Hum & Su Golder & Nader Shaikh, 2018. "Inadequate harms reporting in randomized control trials of antibiotics for pediatric acute otitis media: a systematic review," Drug Safety, Springer, vol. 41(10), pages 933-938, October.
  8. Su Golder & Yoon K Loke & Kath Wright & Gill Norman, 2016. "Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review," PLOS Medicine, Public Library of Science, vol. 13(9), pages 1-22, September.
  9. Su Golder & Yoon K Loke & Martin Bland, 2013. "Comparison of Pooled Risk Estimates for Adverse Effects from Different Observational Study Designs: Methodological Overview," PLOS ONE, Public Library of Science, vol. 8(8), pages 1-9, August.
  10. Su Golder & Yoon K Loke & Martin Bland, 2011. "Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview," PLOS Medicine, Public Library of Science, vol. 8(5), pages 1-13, May.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

    Sorry, no citations of working papers recorded.

Articles

  1. Su Golder & Davy Weissenbacher & Karen O’Connor & Sean Hennessy & Robert Gross & Graciela Gonzalez Hernandez, 2022. "Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media," Drug Safety, Springer, vol. 45(9), pages 971-981, September.

    Cited by:

    1. Cristina Micale & Su Golder & Karen O’Connor & Davy Weissenbacher & Robert Gross & Sean Hennessy & Graciela Gonzalez-Hernandez, 2024. "Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media," Drug Safety, Springer, vol. 47(1), pages 81-91, January.

  2. Su Golder & Karen Smith & Karen O’Connor & Robert Gross & Sean Hennessy & Graciela Gonzalez-Hernandez, 2021. "Correction to: A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews," Drug Safety, Springer, vol. 44(2), pages 259-259, February.

    Cited by:

    1. Su Golder & Davy Weissenbacher & Karen O’Connor & Sean Hennessy & Robert Gross & Graciela Gonzalez Hernandez, 2022. "Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media," Drug Safety, Springer, vol. 45(9), pages 971-981, September.

  3. Su Golder & Karen Smith & Karen O’Connor & Robert Gross & Sean Hennessy & Graciela Gonzalez-Hernandez, 2021. "A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews," Drug Safety, Springer, vol. 44(2), pages 167-179, February.

    Cited by:

    1. Su Golder & Davy Weissenbacher & Karen O’Connor & Sean Hennessy & Robert Gross & Graciela Gonzalez Hernandez, 2022. "Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media," Drug Safety, Springer, vol. 45(9), pages 971-981, September.

  4. Su Golder & Stephanie Chiuve & Davy Weissenbacher & Ari Klein & Karen O’Connor & Martin Bland & Murray Malin & Mondira Bhattacharya & Linda J. Scarazzini & Graciela Gonzalez-Hernandez, 2019. "Pharmacoepidemiologic Evaluation of Birth Defects from Health-Related Postings in Social Media During Pregnancy," Drug Safety, Springer, vol. 42(3), pages 389-400, March.

    Cited by:

    1. Bissan Audeh & Florelle Bellet & Marie-Noëlle Beyens & Agnès Lillo-Le Louët & Cédric Bousquet, 2020. "Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project," Drug Safety, Springer, vol. 43(9), pages 835-851, September.

  5. Karen Smith & Su Golder & Abeed Sarker & Yoon Loke & Karen O’Connor & Graciela Gonzalez-Hernandez, 2018. "Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab," Drug Safety, Springer, vol. 41(12), pages 1397-1410, December.

    Cited by:

    1. Bissan Audeh & Florelle Bellet & Marie-Noëlle Beyens & Agnès Lillo-Le Louët & Cédric Bousquet, 2020. "Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project," Drug Safety, Springer, vol. 43(9), pages 835-851, September.
    2. Ruixue Hu & Su Golder & Guoyan Yang & Xun Li & Di Wang & Liqiong Wang & Ruyu Xia & Nanqi Zhao & Sainan Fang & Baoyong Lai & Jianping Liu & Yutong Fei, 2019. "Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine," PLOS ONE, Public Library of Science, vol. 14(11), pages 1-14, November.

  6. Su Golder & Yoon K Loke & Kath Wright & Gill Norman, 2016. "Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review," PLOS Medicine, Public Library of Science, vol. 13(9), pages 1-22, September.

    Cited by:

    1. Eliane Rohner & Michael Grabik & Thomy Tonia & Peter Jüni & Frank Pétavy & Francesco Pignatti & Julia Bohlius, 2017. "Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-," PLOS ONE, Public Library of Science, vol. 12(12), pages 1-13, December.
    2. Richeek Pradhan & Sonal Singh, 2018. "Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis," Drug Safety, Springer, vol. 41(9), pages 849-857, September.
    3. Luca Aquilanti & Marco Mascitti & Lucrezia Togni & Maria Contaldo & Giorgio Rappelli & Andrea Santarelli, 2022. "A Systematic Review on Nerve-Related Adverse Effects following Mandibular Nerve Block Anesthesia," IJERPH, MDPI, vol. 19(3), pages 1-15, January.
    4. Guillermo Prada-Ramallal & Bahi Takkouche & Adolfo Figueiras, 2017. "Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches," Drug Safety, Springer, vol. 40(7), pages 547-558, July.
    5. Christen M. Gray & Fiona Grimson & Deborah Layton & Stuart Pocock & Joseph Kim, 2020. "A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World Data," Drug Safety, Springer, vol. 43(7), pages 623-633, July.
    6. Sohrabpour, Vahid & Oghazi, Pejvak & Toorajipour, Reza & Nazarpour, Ali, 2021. "Export sales forecasting using artificial intelligence," Technological Forecasting and Social Change, Elsevier, vol. 163(C).

  7. Su Golder & Yoon K Loke & Martin Bland, 2013. "Comparison of Pooled Risk Estimates for Adverse Effects from Different Observational Study Designs: Methodological Overview," PLOS ONE, Public Library of Science, vol. 8(8), pages 1-9, August.

    Cited by:

    1. Amy Lanza & Philippe Ravaud & Carolina Riveros & Agnes Dechartres, 2016. "Comparison of Estimates between Cohort and Case–Control Studies in Meta-Analyses of Therapeutic Interventions: A Meta-Epidemiological Study," PLOS ONE, Public Library of Science, vol. 11(5), pages 1-12, May.
    2. Stephen J. W. Evans, 2016. "What Is the Plural of a ‘Yellow’ Anecdote?," Drug Safety, Springer, vol. 39(1), pages 1-3, January.

  8. Su Golder & Yoon K Loke & Martin Bland, 2011. "Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview," PLOS Medicine, Public Library of Science, vol. 8(5), pages 1-13, May.

    Cited by:

    1. Amy Lanza & Philippe Ravaud & Carolina Riveros & Agnes Dechartres, 2016. "Comparison of Estimates between Cohort and Case–Control Studies in Meta-Analyses of Therapeutic Interventions: A Meta-Epidemiological Study," PLOS ONE, Public Library of Science, vol. 11(5), pages 1-12, May.
    2. Rockers, Peter C. & Røttingen, John-Arne & Shemilt, Ian & Tugwell, Peter & Bärnighausen, Till, 2015. "Inclusion of quasi-experimental studies in systematic reviews of health systems research," Health Policy, Elsevier, vol. 119(4), pages 511-521.
    3. Su Golder & Yoon K Loke & Martin Bland, 2013. "Comparison of Pooled Risk Estimates for Adverse Effects from Different Observational Study Designs: Methodological Overview," PLOS ONE, Public Library of Science, vol. 8(8), pages 1-9, August.
    4. Guillermo Prada-Ramallal & Bahi Takkouche & Adolfo Figueiras, 2017. "Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches," Drug Safety, Springer, vol. 40(7), pages 547-558, July.
    5. Mathur, Maya B & VanderWeele, Tyler, 2021. "Methods to address confounding and other biases in meta-analyses: Review and recommendations," OSF Preprints v7dtq, Center for Open Science.
    6. Sauman Singh-Phulgenda & Prabin Dahal & Roland Ngu & Brittany J Maguire & Alice Hawryszkiewycz & Sumayyah Rashan & Matthew Brack & Christine M Halleux & Fabiana Alves & Kasia Stepniewska & Piero L Oll, 2021. "Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 15(3), pages 1-21, March.
    7. Tina Ljungberg & Emma Bondza & Connie Lethin, 2020. "Evidence of the Importance of Dietary Habits Regarding Depressive Symptoms and Depression," IJERPH, MDPI, vol. 17(5), pages 1-18, March.
    8. Ying Wu & Hong-Bing Liu & Xue-Fei Shi & Yong Song, 2014. "Conventional Hypoglycaemic Agents and the Risk of Lung Cancer in Patients with Diabetes: A Meta-Analysis," PLOS ONE, Public Library of Science, vol. 9(6), pages 1-10, June.
    9. Valérie Seegers & Ludovic Trinquart & Isabelle Boutron & Philippe Ravaud, 2013. "Comparison of Treatment Effect Estimates for Pharmacological Randomized Controlled Trials Enrolling Older Adults Only and Those including Adults: A Meta-Epidemiological Study," PLOS ONE, Public Library of Science, vol. 8(5), pages 1-5, May.
    10. Mingkwan Na Takuathung & Wannachai Sakuludomkan & Rapheephorn Khatsri & Nahathai Dukaew & Napatsorn Kraivisitkul & Balqis Ahmadmusa & Chollada Mahakkanukrauh & Kachathip Wangthaweesap & Jirakit Onin &, 2022. "Adverse Effects of Angiotensin-Converting Enzyme Inhibitors in Humans: A Systematic Review and Meta-Analysis of 378 Randomized Controlled Trials," IJERPH, MDPI, vol. 19(14), pages 1-13, July.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Susan Golder should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.